ESOPJun 15, 2026, 04:12 PM
Milestone Pharma Shareholders Approve 6.8M Share Increase for Equity Plan
AI Summary
Milestone Pharmaceuticals Inc. shareholders approved an amendment to the 2019 Equity Incentive Plan, increasing the number of ordinary shares authorized for issuance by 6,800,000. Additionally, shareholders elected eight directors to the Board, ratified PricewaterhouseCoopers LLP as the company's auditor, and approved the non-binding advisory vote on executive compensation. All proposals presented at the Annual Meeting on June 10, 2026, were passed.
Key Highlights
- Shareholders approved a 6,800,000 share increase for the 2019 Equity Incentive Plan.
- The 2019 Equity Incentive Plan amendment passed with 19,262,773 votes For.
- Eight director nominees were elected to the Board of Directors.
- PricewaterhouseCoopers LLP was ratified as the company's auditor with 75,025,285 votes For.
- The non-binding advisory vote on executive compensation passed with 19,665,705 votes For.
Price Impact
More from MIST